Latest filings (excl ownership)
EFFECT
Notice of effectiveness
3 May 24
S-3
Shelf registration
17 Apr 24
8-K
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation
5 Apr 24
8-K
IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock
27 Mar 24
8-K
Entry into a Material Definitive Agreement
21 Mar 24
424B5
Prospectus supplement for primary offering
21 Mar 24
8-K
Departure of Directors or Certain Officers
13 Mar 24
10-Q
2024 Q3
Quarterly report
14 Feb 24
424B5
Prospectus supplement for primary offering
31 Jan 24
EFFECT
Notice of effectiveness
9 Jan 24
CORRESP
Correspondence with SEC
4 Jan 24
UPLOAD
Letter from SEC
4 Jan 24
S-3
Shelf registration
29 Dec 23
10-Q
2024 Q2
Quarterly report
9 Nov 23
8-K
Entry into a Material Definitive Agreement
27 Oct 23
424B5
Prospectus supplement for primary offering
27 Oct 23
EFFECT
Notice of effectiveness
6 Oct 23
CORRESP
Correspondence with SEC
4 Oct 23
S-8
Registration of securities for employees
3 Oct 23
UPLOAD
Letter from SEC
3 Oct 23
S-3
Shelf registration
29 Sep 23
8-K
IGC Announces Results of its 2023 Annual Stockholders Meeting
21 Aug 23
10-Q
2024 Q1
Quarterly report
10 Aug 23
DEF 14A
Definitive proxy
26 Jul 23
10-K
2023 FY
Annual report
7 Jul 23
8-K
IGC Pharma Secures $12 Million Line of Credit from O-Bank
7 Jul 23
8-K
IGC Pharma Announces a $3 Million Private Placement of its Common Stock
6 Jul 23
NT 10-K
Notice of late annual filing
30 Jun 23
8-K
Departure of Directors or Certain Officers
5 May 23
8-K
Amendments to Articles of Incorporation or Bylaws
21 Mar 23
10-Q
2023 Q3
Quarterly report
14 Feb 23
8-K
Departure of Directors or Certain Officers
29 Dec 22
8-K
Regulation FD Disclosure
20 Dec 22
10-Q
2023 Q2
Quarterly report
1 Nov 22
8-K
IGC Announces Results of its 2022 Annual Stockholders Meeting
9 Sep 22
10-Q
2023 Q1
Quarterly report
5 Aug 22
DEF 14A
Definitive proxy
25 Jul 22
10-K
2022 FY
Annual report
22 Jun 22
8-K
IGC Receives U.S. Patent for Method and Composition for Treating Seizure Disorders
9 Jun 22
8-K
Entry into a Material Definitive Agreement
12 May 22
Latest ownership filings
4
RAM MUKUNDA
18 Mar 24
4
CLAUDIA GRIMALDI
15 Mar 24
4
RICHARD K PRINS
15 Mar 24
4
James P Moran
15 Mar 24
144
Notice of proposed sale of securities
15 Mar 24
4
TERRY L LIERMAN
15 Mar 24
3
TERRY L LIERMAN
12 Mar 24
4
CLAUDIA GRIMALDI
28 Jun 23
4
James P Moran
28 Jun 23
4
RICHARD K PRINS
27 Jun 23
4
RAM MUKUNDA
27 Jun 23
5
RAM MUKUNDA
12 May 23
4
RICHARD K PRINS
28 Jun 22
4
John Edward LYNCH
28 Jun 22
4
CLAUDIA GRIMALDI
28 Jun 22
4
RAM MUKUNDA
28 Jun 22
4
James P Moran
28 Jan 22
3
James P Moran
26 Jan 22
4
RICHARD K PRINS
27 Dec 21
4
RAM MUKUNDA
23 Dec 21
4
CLAUDIA GRIMALDI
23 Dec 21
144
Notice of proposed sale of securities
17 Sep 21
3/A
John Edward LYNCH
15 Sep 21
4/A
RAM MUKUNDA
15 Sep 21
5/A
CLAUDIA GRIMALDI
15 Sep 21
3
John Edward LYNCH
4 Jun 21
4
ROHIT GOEL
19 May 21
5
CLAUDIA GRIMALDI
17 May 21
4
RICHARD K PRINS
14 May 21
4
RAM MUKUNDA
14 May 21
4
RICHARD K PRINS
10 Mar 21
4
RICHARD K PRINS
8 Mar 21
4
RAM MUKUNDA
8 Mar 21
144
Notice of proposed sale of securities
2 Mar 21
4
RICHARD K PRINS
4 Dec 20
4
RAM MUKUNDA
2 Dec 20
144
Notice of proposed sale of securities
30 Nov 20
5/A
RAM MUKUNDA
15 Jun 20
5/A
RICHARD K PRINS
15 Jun 20
5/A
CLAUDIA GRIMALDI
15 Jun 20